Clinical Trial Update: Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing long-term efficacy and safety of Eryfotona AK-NMSC in patients with actinic keratosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Eryfotona AK-NMSC

Snippet

Sponsor: ISDIN | Conditions: Actinic Keratosis | Phase 4 | Status: UNKNOWN